Theriva Biologics
TOVX
TOVX
21 hedge funds and large institutions have $1.3M invested in Theriva Biologics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
21
Holding in Top 10
–
Calls
$3.55M
Puts
–
Top Buyers
| 1 | +$55.7K | |
| 2 | +$34.7K | |
| 3 | +$13K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$8.07K |
Top Sellers
| 1 | -$312K | |
| 2 | -$294K | |
| 3 | -$88K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9.88K |
| 5 |
Two Sigma Investments
New York
|
-$6K |